Photorefractive keratectomy for astigmatism greater than -2.00 diopters in eyes with low, high, or extreme myopia

J Cataract Refract Surg. 1998 Nov;24(11):1456-63. doi: 10.1016/s0886-3350(98)80166-1.

Abstract

Purpose: To assess the efficacy of excimer laser photorefractive astigmatic keratectomy (PARK) in correcting astigmatism of more than -2.00 diopters (D) in eyes with low, high, and extreme myopia.

Setting: Pusan National University Hospital, Pusan, Korea.

Methods: Eighty-five patients (110 eyes) whose spherical error ranged from -3.00 to -13.00 D and cylinder ranged from -2.00 to -5.50 D had PARK with a VISX Twenty-Twenty excimer laser; follow-up was 6 months. All cases of myopic astigmatism were treated using the elliptical method and multizone ablation technique. Eyes were divided into 3 groups: low myopia, less than 6.00 D (n = 47); high myopia, from 6.25 to 10.00 D (n = 43); extreme myopia, over 10.25 D (n = 20). Alpins vector analysis was used to calculate the astigmatic change.

Results: By vector analysis, the success rate of astigmatic correction was more predictable in the low and high myopia groups than in the extreme myopia group (P < .05). There was little improvement in astigmatism in the extreme myopia group.

Conclusion: Using PARK to correct astigmatism greater than -2.00 D in eyes with myopia less than -10.00 D tended to result in undercorrection; astigmatic correction in eyes with myopia over 10.25 D was minimal.

MeSH terms

  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Astigmatism / complications
  • Astigmatism / drug therapy
  • Astigmatism / surgery*
  • Cornea / drug effects
  • Cornea / surgery*
  • Diclofenac / administration & dosage
  • Female
  • Follow-Up Studies
  • Humans
  • Lasers, Excimer
  • Male
  • Middle Aged
  • Myopia / complications
  • Myopia / drug therapy
  • Myopia / surgery*
  • Photorefractive Keratectomy*
  • Treatment Outcome
  • Visual Acuity

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Diclofenac